Hair Transplant

Combining PRP with pharmacological support during FUE hair transplantation significantly improves follicle survival, growth rates, and hair strength compared to pharmacological support alone.

Established therapies such as oral finasteride, topical minoxidil, and hair transplantation can reduce hair loss and promote regrowth in many patients, although response varies and novel approaches are needed.

Emerging therapies such as low-level laser therapy, microneedling, platelet-rich plasma, and stem cell therapy show promise for promoting hair regrowth, while conventional treatments like minoxidil and finasteride remain effective but have limitations.

Various over-the-counter, prescription, and procedural treatments successfully promote hair growth, suggesting that a multifaceted, individualized approach is most effective.

Topical and oral minoxidil and topical finasteride may be useful for pediatric androgenetic alopecia, and hair transplantation can be considered for selected female cases.

Topical minoxidil remains the first-choice treatment with high evidence, though approximately 40% of patients do not respond to it.

Platelet lysate (PL) significantly improved hair regrowth compared to activated PRP and saline in hair transplant grafts, with near-complete regrowth at 4 months; PL injection alone also boosted follicular unit and hair density by 50% and 122% respectively at 7 months.

The review discusses various promising topical, oral, and energy-based therapies, noting growing evidence for their efficacy in treating hair loss.

At 4 years post-surgery, a significant portion of patients experienced reduction in transplanted hair density, with over 55% showing moderate reduction and 8% showing great reduction.

The review provides an overview of follicular unit transplantation techniques and establishes guidelines for identifying suitable candidates for hair restoration surgery.

Follicular unit transplantation provides more natural and discreet results with minimal downtime compared to older hair transplant techniques.

The review outlines various FDA-approved and non-FDA-approved therapies for AGA, emphasizing that treatment selection must balance efficacy, side effects, compliance, and cost.

The article provides a clinical overview of hair transplantation techniques and management protocols rather than reporting specific efficacy data.

Robotic hair transplantation provides a precise and efficient, minimally invasive method for follicular unit removal, though it requires surgeon judgment for design and placement.

FUE can yield excellent results in experienced hands, overcoming scarring associated with FUT, and is applicable for various alopecia and scar corrections.

First-line therapies recommended include oral finasteride 1 mg daily, oral dutasteride 0.5 mg daily, topical 5% minoxidil twice daily for MPHL and topical 1% minoxidil twice daily for FPHL, along with low-level laser therapy and hair transplantation.

The review highlights several emerging therapies, including novel excipients for oral minoxidil, dutasteride, and finasteride; topical prostaglandin modulators; low-level laser therapy; Wnt pathway activators and stem cell treatments for androgenetic alopecia; JAK inhibitors for alopecia areata; antiandrogens and pioglitazone for frontal fibrosing alopecia; and robotic-assisted follicular unit extraction for hair transplantation.

Hair transplant surgery is effective for creating natural-appearing hair in men, though optimal harvesting techniques and adjunctive therapies remain subjects of debate.

Current treatments (minoxidil, finasteride) offer limited and non-permanent benefits; hair transplantation is the only permanent option, while other off-label agents and laser therapies are commonly used despite modest or inconsistent efficacy.

Minoxidil and finasteride remain the standard treatments, with hair transplantation as a surgical option; dutasteride, ketoconazole, and prostaglandin analogues (latanoprost, bimatoprost) are used or under investigation, and low-level laser therapy is gaining popularity, though robust clinical trial data proving hair growth efficacy are limited.

FUE enables extraction of individual follicular units with minimal scarring, and automated techniques allow high graft yields exceeding 1000 grafts per day, providing an effective hair restoration option.